Overview
MioDottore operates as Italy’s leading platform that connects patients with doctors, clinics, and hospitals in both private and public sectors. By using its website, patients can browse providers and book medical visits with the most suitable doctor or facility, while clinics and hospitals use the platform to manage patient flow and boost their online presence. The service leverages a nationwide network and is integrated with Docplanner’s international Health Tech ecosystem, enabling providers to reach more patients and streamline scheduling. The company’s goal is to help people live longer, healthier lives by making high-quality medical care easier to access and faster to arrange through technology.
Work here?Claim your company
Simplify's Take
What believers are saying
- Docplanner reached EBITDA profitability in late 2025, strengthening MioDottore’s backing.
- HireDoc launched in April 2026, opening a new physician recruiting revenue stream.
- MioDottore’s 2026 data shows 84% of patients read reviews before choosing doctors.
What critics are saying
- Doctolib and local booking tools attack the same provider acquisition funnel in Italy.
- Custom pricing and annual contracts make churn costly, but slow expansion beyond Italy.
- Patient booking shifts to WhatsApp and phone; MioDottore captured only 52.38% in 2026.
What makes MioDottore unique
- MioDottore dominates Italy’s patient acquisition with bookings, reviews, and provider profiles.
- Docplanner’s 2026 AI pivot adds Noa Notes, Noa Booking, and Noa Evidence.
- ASL Roma 1 adopted MioDottore in May 2026 for public-sector scheduling and screenings.
Help us improve and share your feedback! Did you find this helpful?